Average Co-Inventor Count = 5.43
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Cardiovascular Systems, Inc. (10 from 1,185 patents)
2. Forsight Vision4, Inc. (5 from 50 patents)
3. Advanced Cardiovascular Systems, Inc. (4 from 1,523 patents)
4. Medarex Inc. (4 from 152 patents)
23 patents:
1. 10765677 - Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
2. 10363255 - Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
3. 9968603 - Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
4. 9895369 - Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
5. 9474756 - Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
6. 9358268 - Lipid therapy
7. 8895056 - Regional delivery of therapeutic agents for the treatment of vascular diseases
8. 8870847 - Blood vessel permeability-enhancement for the treatment of vascular diseases
9. 8785382 - Lipid therapy
10. 8748394 - Apo A-I mimetic peptides and methods of treatment
11. 8735344 - Sustained release of APO A-I mimetic peptides and methods of treatment
12. 8703167 - Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug
13. 8658194 - Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same
14. 8383592 - Apo A-I mimetic peptides and methods of treatment
15. 8309112 - Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same